Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

BACKGROUND Nonadherence among hemodialysis patients compromises dialysis delivery, which could influence patient morbidity and mortality. The Dialysis Outcomes and Practice Patterns Study (DOPPS) provides a unique opportunity to review this problem and its determinants on a global level. METHODS Nonadherence was studied using data from the DOPPS, an international, observational, prospective hemodialysis study. Patients were considered nonadherent if they skipped one or more sessions per month, shortened one or more sessions by more than 10 minutes per month, had a serum potassium level openface>6.0 mEq/L, a serum phosphate level openface>7.5 mg/dL (>2.4 mmol/L), or interdialytic weight gain (IDWG)>5.7% of body weight. Predictors of nonadherence were identified using logistic regression. Survival analysis used the Cox proportional hazards model adjusting for case-mix. RESULTS Skipping treatment was associated with increased mortality [relative risk (RR) = 1.30, P = 0.01], as were excessive IDWG (RR = 1.12, P = 0.047) and high phosphate levels (RR = 1.17, P = 0.001). Skipping also was associated with increased hospitalization (RR = 1.13, P = 0.04), as were high phosphate levels (RR = 1.07, P = 0.05). Larger facility size (per 10 patients) was associated with higher odds ratios (OR) of skipping (OR = 1.03, P = 0.06), shortening (OR = 1.03, P = 0.05), and IDWG (OR = 1.02, P = 0.07). An increased percentage of highly trained staff hours was associated with lower OR of skipping (OR = 0.84 per 10%, P = 0.02); presence of a dietitian was associated with lower OR of excessive IDWG (OR = 0.75, P = 0.08). CONCLUSION Nonadherence was associated with increased mortality risk (skipping treatment, excessive IDWG, and high phosphate) and with hospitalization risk (skipping, high phosphate). Certain patient/facility characteristics also were associated with nonadherence.

[1]  F. Valderrábano,et al.  Quality of life in end-stage renal disease patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  C. Tomson,et al.  Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  D. Mapes,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): How Can We Improve the Care of Hemodialysis Patients? , 2001, Seminars in dialysis.

[4]  P. Kimmel,et al.  Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  N W Levin,et al.  Design and statistical issues of the hemodialysis (HEMO) study. , 2000, Controlled clinical trials.

[6]  M. Rocco,et al.  Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  L. Morgan A decade review: methods to improve adherence to the treatment regimen among hemodialysis patients. , 2000, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.

[8]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  R. Jindal,et al.  Non-Compliance in Patients Receiving Haemodialysis: An In-Depth Review , 2000, Nephron.

[10]  M. Rocco,et al.  Management of Hyperphosphatemia with Calcium‐Based Binders , 1999 .

[11]  B. Hylander,et al.  An international study of patient compliance with hemodialysis. , 1999, JAMA.

[12]  S. Bander,et al.  Hemodialysis morbidity and mortality: links to patient non-compliance. , 1998, Current opinion in nephrology and hypertension.

[13]  F. Port,et al.  Noncompliance in hemodialysis: predictors and survival analysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  O. Ifudu,et al.  Effect of Missed Hemodialysis Treatments on Mortality in Patients with End-Stage Renal Disease , 1998, Nephron.

[15]  A. Testa,et al.  The other side of the coin: interdialytic weight gain as an index of good nutrition. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  F. Port,et al.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[18]  O. Ifudu,et al.  Effect of missed hemodialysis treatments on mortality in patients with end-stage renal disease. , 1997, Nephron.

[19]  R. Hetzer,et al.  FACTORS INFLUENCING THE POSSIBILITY OF WEANING FROM MECHANICAL CARDIAC SUPPORT SYSTEMS IN PATIENTS WITH END-STAGE IDIOPATHIC DILATED CARDIOMYOPATHY , 1997 .

[20]  J T Daugirdas,et al.  The dose of hemodialysis and patient mortality. , 1996, Kidney international.

[21]  P. Kimmel,et al.  Behavioral compliance with dialysis prescription in hemodialysis patients. , 1995, Journal of the American Society of Nephrology : JASN.

[22]  B. Charra,et al.  Survival as an index of adequacy of dialysis. , 1992, Kidney international.

[23]  F. Port,et al.  Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  R. Wolfe,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study , 2000 .

[25]  G. Boscutti,et al.  Behaviour of phosphate removal with different dialysis schedules. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  T. Babazono,et al.  Current status of renal replacement therapy in Japan. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.